Publication | Closed Access

CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study

OncologyHepatologyMedicineTransarterial ChemoembolizationPharmacotherapyLiver CancerCancer TreatmentPharmacologyCallispheres® Drug-eluting BeadsCancer ResearchRadiologyCtilc Study